Article (Scientific journals)
Le pimecrolimus (Elidel) hors des sentiers battus.
Hermanns-Lê, Trinh; Hermanns, Jean-François; Thirion, Laurence et al.
2006In Revue Médicale de Liège, 61 (4), p. 256-9
Peer reviewed
 

Files


Full Text
PIMECROLIMUS.pdf
Publisher postprint (444.27 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Dermatologic Agents/therapeutic use; Humans; Skin Diseases/drug therapy; Tacrolimus/analogs & derivatives/therapeutic use
Abstract :
[en] Pimecrolimus is an immune downregulator that belongs to the class of calcineurin inhibitors. Its efficacy is recognized for the topical treatment of the mild to moderate types of atopic dermatitis. In addition, the drug shows activity in a series of other dermatitides. We report a review of the international literature about this topic.
Disciplines :
Dermatology
Author, co-author :
Hermanns-Lê, Trinh ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Hermanns, Jean-François ;  Université de Liège - ULiège > Département des sciences cliniques > Dermatopathologie
Thirion, Laurence;  CHU > Dermatologie
Pierard, Claudine ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Pierard, Gérald ;  Centre Hospitalier Universitaire de Liège - CHU > Dermatopathologie
Language :
French
Title :
Le pimecrolimus (Elidel) hors des sentiers battus.
Alternative titles :
[en] Pimecrolimus (Elidel) for a variety of skin diseases.
Publication date :
2006
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
61
Issue :
4
Pages :
256-9
Peer reviewed :
Peer reviewed
Available on ORBi :
since 16 March 2009

Statistics


Number of views
140 (1 by ULiège)
Number of downloads
423 (6 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi